Man Group, a UK-based worldwide investment management company, has just completed its acquisition of a 51% participation in Asteria Investment Managers, a Geneva-based, ESG-oriented asset manager, from the Italian private bank Fideuram – Intesa Sanpaolo Private Banking.
Tags :Slider
Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, announced today that it has entered into an asset purchase agreement with Amplyx Pharmaceuticals, an affiliate of Pfizer, to acquire the rights to fosmanogepix, a clinical-stage broad-spectrum antifungal candidate.
The insurer AXA has acquired the successful Swiss fleet manager CarNet. AXA intends to gradually integrate CarNet Management into its subsidiary for mobil
Highlight Event and Entertainment, which is listed on the SIX Swiss Exchange, has completed a rights offering with net proceeds of CHF 41.2 million. The new shares were subscribed by or placed with existing shareholders, several
Herbert Smith Freehills has officially confirmed the re-appointment of Justin D’Agostino as Chief Executive Officer for a second term, effective from May 1, 2024. The decision, following a partnership vote, ensures that D’Agostino will continue
TD Cowen, a division of TD Securities, has sold its Continental European investment banking business to management and their partners. The current partners of the Cowen Europe Group are taking over the Continental European investment
ASSEPRO group has been sold to The Ardonagh Group, a UK independent insurance distribution platform. Niederer Kraft Frey has advised EMZ on the sale. EMZ is an European investment firm which activities are focus on
CONVOTIS has acquisted JMC Group and is entering the Swiss IT market as a platform company and strengthening its position in the managed services and digital platform solutions segment. This acquisition not only provides an
Coop, one of Switzerland’s largest retail and wholesale companies, has tapped embedded finance fintech Additiv to launch its new financial services app Coop Finance+. With this new service, in collaboration with several partners in
Memo Therapeutics, a late-stage biotech firm specializing in top-tier therapeutic antibodies, disclosed the successful conclusion of its CHF 25 million Series C funding round. This milestone was spearheaded by Pureos Bioventures, with strong participation from Memo
